Modulating Exercise Dosage to Improve Concussion Recovery
Recruiting · NCT05434130 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Colorado, Denver
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Aerobic exercise has emerged as an effective treatment to reduce sport-related concussion symptom severity, yet existing work lacks rigor regarding the precise exercise volume and intensity required to elicit therapeutic effects, how exercise can alter concussion-related pathophysiology, and whether exercise can prevent the development of secondary sequelae. Our objective is to examine if a high dose exercise program (higher volume than currently prescribed at an individualized, safe intensity level) initiated within 21 days of concussion results in faster symptom resolution, altered physiological function, or reduced secondary sequalae. Findings from this research will lead to more rigorous and precise rehabilitation guidelines and improved understanding about how exercise affects neurophysiological function among adolescents with concussion.
Who can take part
Inclusion criteria
- 13-18 years of age
- Post-Concussion Symptom Scale (PCSS) score \>10 to ensure participants are not recovered by enrollment
- Concussion diagnosis by a sports medicine physician
Exclusion criteria
- Pre-existing neurological disorders
- Exercise contraindications
- Concussion \<6 months before enrollment (excluding the current injury)
Where it is running
3 locations listed across 2 US states.
- University of Colorado Denver - Aurora, Colorado, United States
- Boston Children's Hospital - Boston, Massachusetts, United States
- Spaulding Rehabilitation Hospital - Cambridge, Massachusetts, United States